Lucy Shapiro, Director at Anacor Pharmaceuticals Inc (ANAC), sold 20,000 shares at $6.35 ($127K) on 2012-09-24, disclosed to the SEC on 2012-09-24.
Scheduled sale ($126k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.30 | 10,000 | $63K | 49.8% |
| 2 | $6.35 | 10,000 | $64K | 50.2% |
| Total | $6.33 avg | 20,000 | $127K | 100% |
| Filing → |
| ANAC | SELL | 2014-03-25 | $1.7M | — | Filing → |
| ANAC | SELL | 2013-04-19 | $200K | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |